The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.
Ivell R, Heng K, Severn K, Antonio L, Bartfai G, Casanueva FF, Huhtaniemi IT, Giwercman A, Maggi M, O'Connor DB, O'Neill TW, Punab M, Rastrelli G, Slowikowska-Hilczer J, Tournoy J, Vanderschueren D, Wu FCW, Anand-Ivell R.
Ivell R, et al. Among authors: anand ivell r.
Front Endocrinol (Lausanne). 2022 Nov 8;13:1016107. doi: 10.3389/fendo.2022.1016107. eCollection 2022.
Front Endocrinol (Lausanne). 2022.
PMID: 36425465
Free PMC article.